Company intelligence / Profile preview

Kiro

Paris, France

Ownership: Private
Development stage: Other

Overview

Kiro has developed an AI-driven platform that interprets laboratory results, providing clear, personalized insights to patients and real-time clinical decision support to healthcare professionals. The system increases detection rates of relevant findings by 25% through its medically graded algorithms. It is already deployed in partnership with leading laboratories, hospitals, and physicians across Europe. No traditional drug development or clinical trial results apply.

Therapeutic areas: Other
Modalities: Software as a medical device (AI-powered clinical decision support)Digital biomarker generation
Industry: Digital Health Medical Devices

Partnerships

Partnerships with leading laboratories, hospitals, physiciansSofinnova Partners (investor/accelerator)

Beyond the preview

Go deeper on Kiro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kiro.

Explore the full profile